GRAND RAPIDS, Mich.--(BUSINESS WIRE)--Today Priority Health announced it will offer a new digital prevention tool to help members manage their diabetes. Through its partnership with Omada Health, Priority Health will provide clinically-eligible members access to Omada, the country’s leading digital Diabetes Prevention Program (DPP), beginning this month. Priority Health is the first health plan in Michigan to add the Centers for Disease Control and Prevention (CDC) fully recognized digital Diabetes Prevention Program as a preventive benefit.
Omada offers an evidence-based digital program that empowers people to make sustainable behavioral changes and lower their risk of chronic disease. The company offers an adaptable intervention for employees or members at risk for obesity-related conditions such as type 2 diabetes and heart disease. Leveraging social connectivity, professional health coaches, engaging curriculum, and connected tools, the Omada program is now available to most Priority Health commercial members with prediabetes or at-risk to develop type 2 diabetes.
Read More: https://www.businesswire.com/news/home/20181003005495/en/Priority-Health-Offer-Omada-Health-Virtual-Diabetes
Via: Business Wire
Objective Responses Observed in Heavily-pretreated Ovarian Cancer Patients Treated with Navicixzumab Monotherapy
Cigna Announces Cigna Ventures with $250 Million to Fund Transformative Innovation and Growth for Health Care
BLOOMFIELD, Conn.--(BUSINESS WIRE)--Today, global health service company Cigna (NYSE: CI) announced the launch of Cigna Ventures, a corporate venture fund focused on transformative and innovative health care companies.
Omada Health made its name with its technology. Now it’s luring insurers with operational innovation
Via: Fierce Healthcare
Inside the San Francisco offices of Omada Health, there’s a tongue-in-cheek term used to describe the company: provendor.
OncoMed Pharmaceuticals, Inc. OMED, +6.44% a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced that John Lewicki, Ph.D., President and Chief Executive Officer of OncoMed, will provide a corporate update at two upcoming investor conferences.
Via: Business Wire
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, a commercial-stage company delivering first-of-its-kind technology into the growing global dialysis market, today announced that it raised $132 million in a Series D equity financing. The round was led by new investor Mubadala Investment Company, Abu Dhabi’s leading investment company, active in numerous sectors and more than 30 countries around the world. Existing investors Baxter Ventures, the venture capital arm of Baxter International, Fidelity Management and Research Company, Partner Fund Management LP, Perceptive Advisors, funds advised by T. Rowe Price Associates Inc., and Warburg Pincus also participated in the equity round.
Via: WVU Medicine
MORGANTOWN, W.Va. – Surgeons at the WVU Heart and Vascular Institute are now offering a new minimally invasive treatment for patients with carotid artery disease.
TCAR (Transcarotid Artery Revascularization): The Next Step in the Evolution of Carotid Revascularization
Via: Endovascular Today
Since its introduction in the 1950s, carotid endarterectomy (CEA) has been considered the gold standard treatment option for carotid revascularization. However, in patients with high-risk anatomic and/or physiologic characteristics, CEA is associated with higher rates of adverse outcomes.1 Transfemoral carotid angioplasty and stenting (TF-CAS) was introduced over 2 decades ago as a potential alternative. However, its effectiveness compared to CEA remains unclear, and full adoption of TF-CAS has been hindered by a higher rate of periprocedural stroke.2
Providing advanced medical care in a patient's home once required the help of trained professionals. No longer -- new sensor technology is enabling a massive migration from hospitals to home care environments.
A study presented Monday at the American Diabetes Association (ADA) Scientific Sessions found that one-third of those who initially screened positive for prediabetes or diabetes were able to bring their blood sugar down to normal levels after taking part in a workforce-based intervention.